Cargando…

Altered TIMP-3 Levels in the Cerebrospinal Fluid and Plasma of Patients with Alzheimer’s Disease

Tissue inhibitor of metalloproteinase-3 (TIMP-3) is a component of the extracellular environment and is suggested to play an indirect role in regulating Aβ production and the pathophysiology of Aβ deposition in brains. However, studies on the amount of TIMP-3 in bodily fluids of Alzheimer’s disease...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Jung Hyun, Cho, Sun-Jung, Jo, Chulman, Park, Moon Ho, Han, Changsu, Kim, Eun-Joo, Huh, Gi Yeong, Koh, Young Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144624/ https://www.ncbi.nlm.nih.gov/pubmed/35629249 http://dx.doi.org/10.3390/jpm12050827

Ejemplares similares

Plasma ATG5 is increased in Alzheimer’s disease
por: Cho, Sun-Jung, et al.
Publicado: (2019)

Altered expression of Notch1 in Alzheimer's disease
por: Cho, Sun-Jung, et al.
Publicado: (2019)

VEGFR2 alteration in Alzheimer’s disease
por: Cho, Sun-Jung, et al.
Publicado: (2017)

Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer's Disease in Amnestic Mild Cognitive Impairment
por: Park, Jung Eun, et al.
Publicado: (2019)

The Correlation Study between Plasma Aβ Proteins and Cerebrospinal Fluid Alzheimer's Disease Biomarkers
por: Shin, Ho Sik, et al.
Publicado: (2016)

Altered COVID-19 receptor ACE2 expression in a higher risk group for cerebrovascular disease and ischemic stroke
por: Choi, Ji-Young, et al.
Publicado: (2020)

SWATH-MS analysis of cerebrospinal fluid to generate a robust battery of biomarkers for Alzheimer’s disease
por: Park, Sun Ah, et al.
Publicado: (2020)

Cigarette smoke extracts and cadmium induce COX-2 expression through γ-secretase-mediated p38 MAPK activation in C6 astroglia cells
por: Lim, Hyun Joung, et al.
Publicado: (2019)

Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer’s disease
por: Turri, Marta, et al.
Publicado: (2023)

SARS-CoV-2 spike S1 subunit protein-mediated increase of beta-secretase 1 (BACE1) impairs human brain vessel cells
por: Choi, Ji-Young, et al.
Publicado: (2022)

Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease in South Korea
por: Park, Sun Ah, et al.
Publicado: (2017)

Identification of peripheral inflammatory markers between normal control and Alzheimer's disease
por: Kim, Sam-Moon, et al.
Publicado: (2011)

The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer’s pathology
por: Westwood, Sarah, et al.
Publicado: (2017)

Plasma and cerebrospinal fluid nonenzymatic protein damage is sustained in Alzheimer's disease
por: Dakterzada, Farida, et al.
Publicado: (2023)

Proteome analysis of human cerebrospinal fluid as a diagnostic biomarker in patients with meningioma
por: Kim, Jae Ho, et al.
Publicado: (2012)

Plasma contact factors as novel biomarkers for diagnosing Alzheimer’s disease
por: Park, Jung Eun, et al.
Publicado: (2021)

Curcumin activates Nrf2 through PKCδ-mediated p62 phosphorylation at Ser351
por: Park, Jee-Yun, et al.
Publicado: (2021)

A splicing variant of TFEB negatively regulates the TFEB-autophagy pathway
por: Park, Jee-Yun, et al.
Publicado: (2021)

A map of neurofilament light chain species in brain and cerebrospinal fluid and alterations in Alzheimer’s disease
por: Budelier, Melissa M., et al.
Publicado: (2022)

Increased Albumin Oxidation in Cerebrospinal Fluid and Plasma from Alzheimer’s Disease Patients
por: Costa, Montserrat, et al.
Publicado: (2018)

Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
por: Palmqvist, Sebastian, et al.
Publicado: (2019)

Rubidium and potassium levels are altered in Alzheimer’s disease brain and blood but not in cerebrospinal fluid
por: Roberts, Blaine R., et al.
Publicado: (2016)

Altered Balance of Reelin Proteolytic Fragments in the Cerebrospinal Fluid of Alzheimer’s Disease Patients
por: Lopez-Font, Inmaculada, et al.
Publicado: (2022)

Association between blood lead level and risk of stroke in Korean adults: a cross-sectional study in the Korea National Health and Nutrition Examination Survey 2008–2013
por: Kim, Minkyeong, et al.
Publicado: (2020)

TFEB activates Nrf2 by repressing its E3 ubiquitin ligase DCAF11 and promoting phosphorylation of p62
por: Park, Jee-Yun, et al.
Publicado: (2019)

Levels of islet amyloid polypeptide in cerebrospinal fluid and plasma from patients with Alzheimer’s disease
por: Schultz, Nina, et al.
Publicado: (2019)

Assessment of Plasma and Cerebrospinal Fluid Biomarkers in Different Stages of Alzheimer’s Disease and Frontotemporal Dementia
por: Álvarez-Sánchez, Lourdes, et al.
Publicado: (2023)

Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease
por: Gui, YaXing, et al.
Publicado: (2015)

Cerebrospinal Fluid EV Concentration and Size Are Altered in Alzheimer’s Disease and Dementia with Lewy Bodies
por: Longobardi, Antonio, et al.
Publicado: (2022)

Cerebrospinal Fluid Proteome Alterations Associated with Neuropsychiatric Symptoms in Cognitive Decline and Alzheimer’s Disease
por: Mroczek, Magdalena, et al.
Publicado: (2022)

Effect of nitazoxanide on albendazole pharmacokinetics in cerebrospinal fluid and plasma in rats
por: Ruiz-Olmedo, María Isabel, et al.
Publicado: (2017)

Galeal Tack-Up Sutures to Prevent Subgaleal Cerebrospinal Fluid Collection
por: Choi, Won Ho, et al.
Publicado: (2013)

Cytologic Diagnosis of Metastatic Alveolar Rhabdomyosarcoma in Cerebrospinal Fluid: A Case Report
por: Shim, Bobae, et al.
Publicado: (2018)

Metabolite Profiling of Alzheimer's Disease Cerebrospinal Fluid
por: Czech, Christian, et al.
Publicado: (2012)

Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease
por: Khoonsari, Payam Emami, et al.
Publicado: (2016)

Alzheimer disease pathology and the cerebrospinal fluid proteome
por: Dayon, Loïc, et al.
Publicado: (2018)

Cerebrospinal fluid in Alzheimer's: A precious tool
por: Parnetti, Lucilla, et al.
Publicado: (2016)

Tau oligomers in cerebrospinal fluid in Alzheimer's disease
por: Sengupta, Urmi, et al.
Publicado: (2017)

Expression of Tissue Inhibitors of Metalloproteinases (TIMPs) in Hepatocellular Carcinoma
por: Joo, Young-Eun, et al.
Publicado: (2000)

Diagnostic and prognostic values of cerebrospinal fluid CYFRA 21-1 in patients with leptomeningeal carcinomatosis
por: Hyun, Jae-Won, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_66kbqltg513scmnkdlj3gpij8l